L152-0563 Screening compound: 5-[(3-chlorophenyl)methyl]-N-cycloheptyl-7-methyl-4-oxo-4H,5H-[1,2,4]triazolo[1,5-a]quinoxaline-2-carboxamide

L152-0563 Screening compound: 5-[(3-chlorophenyl)methyl]-N-cycloheptyl-7-methyl-4-oxo-4H,5H-[1,2,4]triazolo[1,5-a]quinoxaline-2-carboxamide
L152-0563 Screening compound: 5-[(3-chlorophenyl)methyl]-N-cycloheptyl-7-methyl-4-oxo-4H,5H-[1,2,4]triazolo[1,5-a]quinoxaline-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L152-0563
5-[(3-chlorophenyl)methyl]-N-cycloheptyl-7-methyl-4-oxo-4H,5H-[1,2,4]triazolo[1,5-a]quinoxaline-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L152-0563

Molecular Formula

C25H26ClN5O2 (C25 H26 ClN5 O2)

Compound Name

5-[(3-chlorophenyl)methyl]-N-cycloheptyl-7-methyl-4-oxo-4H,5H-[1,2,4]triazolo[1,5-a]quinoxaline-2-carboxamide

IUPAC name

5-[(3-chlorophenyl)methyl]-N-cycloheptyl-7-methyl-4-oxo-4H5H-[124]triazolo[15-a]quinoxaline-2-carboxamide

SMILES

Cc(cc1)cc(N2Cc3cccc(Cl)c3)c1-n1nc(C(NC3CCCCCC3)=O)nc1C2=O

InChI

InChI=1S/C25H26ClN5O2/c1-16-11-12-20-21(13-16)30(15-17-7-6-8-18(26)14-17)25(33)23-28-22(29-31(20)23)24(32)27-19-9-4-2-3-5-10-19/h6-8,11-14,19H,2-5,9-10,15H2,1H3,(H,27,32)

InChI Key

MKBMXNASZBEXEX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15119668

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.97

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.567

Distribution Coefficient, logD

5.567

Water Solubility, LogSw

-5.68

Polar Surface Area

63.093

Acid Dissociation Constant (pKa)

13.44

Base Dissociation Constant (pKb)

-4.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

L152-0563 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L152-0563 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L152-0563?
Check Price and Availability of L152-0563, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L152-0563 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L152-0563
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L152-0563
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L152-0563 available by request